PTGX peer analysis
Protagonist Therapeutics (PTGX) against its competitors: price, today's move, 1-year return and market value side by side.
- PTGX's peers: ACRS (Aclaris Therapeutics), ANAB (AnaptysBio), IMUX (Immunic), IMVT (Immunovant), IRON (Disc Medicine), ODTX (Odyssey Therapeutics), SYRE (Spyre Therapeutics).
PTGX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.44 | -1.71% | 39.84% | $545.63M |
| ANAB AnaptysBio | $46.63 | -1.62% | 25.99% | $1.39B |
| IMUX Immunic | $7.03 | -4.87% | -1.44% | $111.64M |
| IMVT Immunovant | $31.51 | -3.11% | 36.05% | $6.52B |
| IRON Disc Medicine | $75.14 | -1.27% | -17.19% | $2.88B |
| ODTX Odyssey Therapeutics | $16.96 | -7.52% | – | $815.23M |
| SYRE Spyre Therapeutics | $93.47 | -4.26% | 284.65% | $8.88B |
| PTGX Protagonist Therapeutics | $121.40 | -2.11% | 42.61% | $7.92B |